A Study of Weekly Tisotumab Vedotin for Patients With Platinum-Resistant Ovarian Cancer With Safety Run-in (innovaTV 208)
Clinical trial NCT03657043 · COMPLETED
Trial details
- NCT number
- NCT03657043
- Sponsor
- Seagen Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-20
- Primary completion
- 2022-02-08
- Enrollment
- 98
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.